|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2004-3-1
|
|
pubmed:abstractText |
To determine whether an angiotensin-converting enzyme (ACE) inhibitor, enalapril, prevents cardiac function deterioration (defined using maximal cardiac index [MCI] on exercise testing or increase in left ventricular end-systolic wall stress [LVESWS]) in long-term survivors of pediatric cancer.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
0732-183X
|
|
pubmed:author |
pubmed-author:BarberGeraldG,
pubmed-author:ChinAlvin JAJ,
pubmed-author:ClarkBernard JBJ,
pubmed-author:CnaanAvitalA,
pubmed-author:CohenMitchell IMI,
pubmed-author:DelaatCynthiaC,
pubmed-author:HogartyAlexa NAN,
pubmed-author:KimballThomas RTR,
pubmed-author:ParidonStephen MSM,
pubmed-author:RutkowskiMonikaM,
pubmed-author:RychikJackJ,
pubmed-author:SilberJeffrey HJH,
pubmed-author:SteinherzLaurel JLJ,
pubmed-author:ZhaoHuaqingH
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
22
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
820-8
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:14990637-Adolescent,
pubmed-meshheading:14990637-Adult,
pubmed-meshheading:14990637-Anthracyclines,
pubmed-meshheading:14990637-Child,
pubmed-meshheading:14990637-Child, Preschool,
pubmed-meshheading:14990637-Disease Progression,
pubmed-meshheading:14990637-Double-Blind Method,
pubmed-meshheading:14990637-Enalapril,
pubmed-meshheading:14990637-Exercise Test,
pubmed-meshheading:14990637-Exercise Tolerance,
pubmed-meshheading:14990637-Female,
pubmed-meshheading:14990637-Follow-Up Studies,
pubmed-meshheading:14990637-Heart Failure,
pubmed-meshheading:14990637-Heart Function Tests,
pubmed-meshheading:14990637-Humans,
pubmed-meshheading:14990637-Linear Models,
pubmed-meshheading:14990637-Male,
pubmed-meshheading:14990637-Neoplasms,
pubmed-meshheading:14990637-Probability,
pubmed-meshheading:14990637-Prognosis,
pubmed-meshheading:14990637-Reference Values,
pubmed-meshheading:14990637-Risk Assessment,
pubmed-meshheading:14990637-Severity of Illness Index,
pubmed-meshheading:14990637-Survivors,
pubmed-meshheading:14990637-Treatment Outcome
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
Enalapril to prevent cardiac function decline in long-term survivors of pediatric cancer exposed to anthracyclines.
|
|
pubmed:affiliation |
Center for Outcomes Research, Children's Hospital of Philadelphia, 3535 Market St, Suite 1029, Philadelphia, PA 19104, USA. Silber@email.chop.edu
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Research Support, U.S. Gov't, P.H.S.,
Randomized Controlled Trial
|
